NDC 55513-224 – Riabni
Rituximab 100 mg/10mL · Injection, Solution · Intravenous
Product NDC55513-224
Product details
- Brand name
- Riabni
- Generic name
- Rituximab-arrx
- Labeler
- Amgen, Inc
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Marketing category
- BLA · BLA761140
- Marketed since
- January 6, 2021
- Listing expires
- December 31, 2027
- Pharmacologic class
- CD20-directed Cytolytic Antibody
Active ingredients
- Rituximab 100 mg/10mL
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 55513-224-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (55513-224-01) / 10 mL in 1 VIAL, SINGLE-DOSE | Jan 6, 2021 |
| 55513-224-21 | 1 VIAL, SINGLE-DOSE in 1 CARTON (55513-224-21) / 10 mL in 1 VIAL, SINGLE-DOSE | Jul 21, 2025 |
Other Riabni products
- 55513-326 Rituximab 500 mg/50mL · Injection, Solution · Amgen, Inc